Sean Maduck, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 78,820 shares at $72.98 ($5.7M) on 2025-05-02, disclosed to the SEC on 2025-05-05.
Scheduled sale ($5.7M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.94 | 12,856 | $925K | 16.3% |
| 2 | $71.94 | 12,856 | $925K | 16.3% |
| 3 | $72.21 | 25,847 | $1.9M | 32.8% |
| 4 | $72.21 | 25,847 | $1.9M | 32.8% |
| 5 | $72.98 | 707 | $52K | 0.9% |
| 6 | $72.98 | 707 |
| $52K |
| 0.9% |
| Total | $72.14 avg | 78,820 | $5.7M | 100% |
| Filing → |
| CORT | SELL | 2026-08-18 | $419K | — | Filing → |
| CORT | SELL | 2026-08-12 | $118K | — | Filing → |
| CORT | SELL | 2026-08-05 | $2.3M | — | Filing → |